ONC challenge spotlights behavioral health

Laura Pedulli | | Health Exec | Precision Medicine

The Office of the National Coordinator for Health IT’s (ONC’s) latest innovation challenge seeks to empower individuals to manage their mental health and substance abuse issues through innovative technologies.

In collaboration with the Substance Abuse and Mental Health Services Administration, ONC’s Behavioral Health Patient Empowerment Challenge encourages developers to submit innovative applications that use evidence-based strategies and that must be available to consumers on a widely-used platform for mobile devices by the Sept. 3 submission date, according to an announcement.

“To be clear, we are interested only in applications that are currently available, and this can include websites optimized for mobile devices,” Adam Wong, management and program analyst, ONC, reiterated on the agency’s website.

The challenge is taking place in conjunction with the Technology Innovations for Substance Abuse and Mental Health Disorders Conference scheduled on Sept. 16 at the White House. The three top finishers will be invited to the conference and the winner will receive an opportunity to present their innovation.

For more information, including submission requirements, go here. 

Laura Pedulli

Related Content

Pitching the business case for 3D printing labs in radiology
FDA issues first-ever clearance for OTC oximeter
Augmented reality company secures $15M in funding from Cleveland Clinic, Mayo, GE Healthcare and more
Merck to acquire Prometheus Biosciences for $10.8B
Johnson & Johnson scraps RSV vaccine after trial
Intermountain Health launches new biotech company

Around the web

Cardiovascular Business
Boston Scientific enters renal denervation market with acquisition worth up to $540M

Boston Scientific has announced another significant M&A deal, scooping up an Israeli medtech company focused on RDN technology. 

Radiology Business
Shift toward imaging outside the hospital could save billions

Harvard’s David A. Rosman, MD, MBA, explains how moving imaging outside of hospitals could save billions of dollars for U.S. healthcare.

Cardiovascular Business
FDA announces catheter recall for Johnson & Johnson PFA system due to stroke risk

The recall comes after approximately 3% of patients treated with the device during the early stages of its U.S. rollout experienced a stroke or transient ischemic attack following surgery. The expected stroke rate is closer to 1%, the FDA explained.